Treatment of LIFR inhibitor, EC359, also showed a trend toward reduced fibrosis, but not statistically significant in the CCl 4 ‐treated mice (Figure 3G ).
← all excerpts
p16<sup>Ink4a</sup>-Positive Hepatocytes Drive Liver Fibrosis Through Activation of LIFR Family Pathway.
1
—
—